UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 2, 2009
CNS RESPONSE, INC.
(Exact name of Company as specified in its charter)
| Delaware | | 0-26285 | | 87-0419387 |
(State or other jurisdiction of incorporation) | | (Commission File No.) | | (I.R.S. Employer Identification No.) |
2755 Bristol Street, Suite 285
Costa Mesa, CA 92626
(Address of principal executive offices)
(714) 545-3288
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events.
On November 3, 2009, CNS Response, Inc. (the “Company”) issued a press release reporting the results of a study presented by Charles DeBattista, D.M.H, M.D., at the U.S. Psychiatric and Mental Health Congress. A copy of the press release is included as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. A copy of the poster presented by Dr. DeBattista on November 2, 2009 at the U.S. Psychiatric and Mental Health Congress is included as Exhibit 99.2 to this Form 8-K and is incorporated herein by reference.
The Company will be holding a conference call to discuss the top-line results of its recently completed study. CNS stockholders are encouraged to participate in the conference call, which will be held today at 8:00 a.m. PST. Please call Suzanne Schnitzer at 949.553.9748 to register for the call. You will be given the toll-free dial-in number and access code to the conference call, along with the login instructions to join the simultaneous web conference. A copy of the materials to be presented by the Company over the web are included as Exhibit 99.3 to this Form 8-K and are incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are filed herewith:
| | |
| 99.1 | Press Release Issued November 3, 2009. |
| 99.2 | Copy of poster presented at U.S. Psychiatric and Mental Health Congress. |
| 99.3 | Copy of web presentation materials. |
SIGNATURES
Pursuant to the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | CNS Response, Inc. |
| | |
| | By: | /s/ George Carpenter |
| November 3, 2009 | | George Carpenter |
| | | Chief Executive Officer |
Exhibit Index
| | |
| 99.1 | Press Release Issued November 3, 2009. |
| 99.2 | Copy of poster presented at U.S. Psychiatric and Mental Health Congress. |
| 99.3 | Copy of web presentation materials. |
